Warning: include(inc/language/.php): failed to open stream: No such file or directory in /homepages/40/d483507699/htdocs/index.php on line 39

Warning: include(): Failed opening 'inc/language/.php' for inclusion (include_path='.:/usr/lib/php5.6') in /homepages/40/d483507699/htdocs/index.php on line 39
Institut Necker Enfants Malades
Notice: Undefined variable: welcome in /homepages/40/d483507699/htdocs/index.php on line 156

Notice: Undefined variable: organigramme in /homepages/40/d483507699/htdocs/index.php on line 170

Notice: Undefined variable: support in /homepages/40/d483507699/htdocs/index.php on line 172

Notice: Undefined variable: legal_mention in /homepages/40/d483507699/htdocs/index.php on line 174
  /     /  

Notice: Undefined variable: yourrequest in /homepages/40/d483507699/htdocs/index.php on line 210

Notice: Undefined variable: job in /homepages/40/d483507699/htdocs/jobs.php on line 10

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 90

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 91
Postdoctoral Scientist in Stem Cell Biology ‐ investigating the development of the haematopoietic system
6

  • Salary in the range of £30,000 ‐ £39,800 (dependent upon qualifications and experience)
  • Job Ref: MI/17/55
  • Commencement of post: January 2018
  • Duration of post: 3 years (in first instance)
We are looking for a highly motivated Postdoctoral Scientist to join the laboratory of Professor Georges Lacaud to investigate the development of the haematopoietic system. Understanding how blood cells are generated is important from a biological perspective but has also tremendous potential implications for the treatment of blood diseases. The successful candidate will perform single cell expression and epigenetic analyses, in collaboration with our Bioinformatician, to reveal new hierarchical relationships, infer pathways of differentiation and uncover new regulatory interactions sustaining blood development. The hypotheses generated in silico will be evaluated using state‐of‐the‐art mouse models, CRISPR genome editing and ES cell cultures.

The applicant should have a PhD in molecular or cellular biology. A background in developmental haematopoiesis is desirable but not required.

Informal enquiries should be directed to Georges Lacaud (georges.lacaud@cruk.manchester.ac.uk).

The Cancer Research UK Manchester Institute (www.cruk.manchester.ac.uk), an Institute of The University of Manchester (www.manchester.ac.uk), is a world‐leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org), the largest independent cancer research organisation in the world. We are currently situated at the internationally‐renowned life sciences campus at Alderley Park in Cheshire, England, 15 miles from Manchester, a vibrant and dynamic city surrounded by beautiful countryside. We are partnered with The Christie NHS Foundation
Trust (adjacent to the CRUK Manchester Institute, Paterson Building) in South Manchester (www.christie.nhs.uk), one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials.

The Institute has outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass‐spectrometry.
To apply for this position please visit our website: www.cruk.manchester.ac.uk.

For applicants who are unable to download this information from our website, please contact HR department on 0161 306 0840, email: jobs@cruk.manchester.ac.uk to have this information sent by post.

Closing date: 25 September 2017.

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 90

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 91
Postdoctoral Scientist in Stem Cell Biology - identifying candidate therapeutic targets for potential drug development
6

  • Salary in the range of £30,000 ‐ £39,800 (dependent upon qualifications and experience)
  • Job Ref: MI/17/56
  • Commencement of post: January 2018
  • Duration of post: 3 years (in first instance)

A 3‐year position is available for a highly motivated postdoctoral scientist in the laboratory of Professor Georges Lacaud to investigate the roles of the transcription factor RUNX1 and/or the epigenetic factor MOZ in normal haematopoiesis and leukemia. The successful applicant will use different mouse models already available in the laboratory to identify genes and pathways regulated by these two transcriptional regulators either in normal or malignant haematopoiesis. Their relevance will be evaluated using state‐of‐the‐art mouse models, CRISPR genome editing, ES cell and primary human leukaemia cell cultures. The ultimate goal of this work is to identify candidate therapeutic targets for potential drug development. The successful applicant should have a PhD in molecular or cellular biology. A background in haematopoiesis or leukaemia is desirable but not required.

Informal enquiries should be directed to Georges Lacaud (georges.lacaud@cruk.manchester.ac.uk).

The Cancer Research UK Manchester Institute (www.cruk.manchester.ac.uk), an Institute of The University of Manchester (www.manchester.ac.uk), is a world‐leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org), the largest independent cancer research organisation in the world. We are currently situated at the internationally‐renowned life sciences campus at Alderley Park in Cheshire, England, 15 miles from Manchester, a vibrant and dynamic city surrounded by beautiful countryside. We are partnered with The Christie NHS Foundation Trust (adjacent to the CRUK Manchester Institute, Paterson Building) in South Manchester (www.christie.nhs.uk), one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials. The Institute has outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass‐spectrometry.

To apply for this position please visit our website: www.cruk.manchester.ac.uk. For applicants who are unable to download this information from our website, please contact HR department on 0161 306 0840, email: jobs@cruk.manchester.ac.uk to have this information sent by post.

Closing date: 25 September 2017.

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 90

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 91
Post-doctoral fellowship on Cystic Fibrosis airway disease
22
Cystic fibrosis (CF) is due to mutations in the gene coding for the CFTR chloride channel and is characterized by a persistent and ineffective inflammation of the airway. During the inflammatory process, mediators specialized in the resolution of inflammation, called SPM or specialized pro-resolving mediators (lipoxins, resolvins…), are normally produced from lipoxygenase interactions. We previously demonstrated that these SPMs play a central role in the regulation of innate immunity in restoring ion transport abnormalities in CF airways (Higgins et al, Am J Physiol Lung Cell Mol Physiol. 2016, Higgins et al, Am J Respir Cell Mol Biol. 2014, Buchanan et al, Am J Physiol Lung Cell Mol Physiol. 2013) and are atypically produced in the airway of patients (Ringholz et al, Eur Respir J. 2014).
The goal of this project is to identify the cellular and molecular mechanism involved in the defective production of SPM in cystic fibrosis and to test, in particular, the role of the CFTR protein and CFTR mutations on the biosynthesis and activity of lipoxygenases using biochemistry, molecular biology, interactomic and advanced confocal microscopy approaches.
Candidates for this project should have a solid background in cell culture, molecular biology (transfection, real time PCR), biochemistry (Western Blot, co-immunoprecipitation, immunohistochemistry) and confocal microscopy.


Candidates should e-mail their application, including a CV, a letter of motivation and at least two reference letters to:

Valérie Urbach
Institut Necker Enfants Malades, INSERM U1151, Paris, France
valerie.urbach@gmail.com
tel: +33 (0)6 30 37 59 04

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 90

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 91
Post-doctoral position "Exosome contribution to endoplasmic reticulum (ER) protein quality control in cystic fibrosis (and other epithelial protein misfolded diseases (PMD))"
16
A post-doctoral position is currently available for 14 months (renewable) in the team Chanelopathies: cystic fibrosis and other diseases, of Research Center "Institut Necker Enfants Malades", INSERM U1151, Faculté Necker, Paris, France.

Salary: 56.000 € / year

Mission:
Our research concerns the mechanisms involved in Cystic Fibrosis (CF), a lethal genetic disease due to mutations in CF gene. The most frequent mutation, F508del, leads to CFTR misfolding and preferential degradation at the ER, which constitutes the primary cause of the channel functional expression defect at cell surface. Exosomes (EXs), as part of extracellular vesicle populations, have been shown to contain CFTR. Investigating the contribution of selective autophagocytosis of mutated CFTR proteins may bring further insights into in the molecular and cellular pathogenesis of CF, as well as the role of exosome in clearance of misfolded proteins from ER. The study may be extended to other PMD.
The post-doctoral project lies at the interface of biochemistry, molecular cell biology and proteomics, aiming to investigate involvement of EXs in the trafficking and function of CFTR variants. EXs biogenesis and composition, as well as CFTR metabolism will be established in non-polarized cells and epithelia in the presence and absence of CFTR expression. The role of selective autophagocytosis will be probed in parallel by genetic means (siRNA, Crispr). The project will require experience in protein biochemistry, molecular biology, various microscopic and immunochemical techniques. Collaboration with mass spectrometry team is in place.

Profile:
Candidates for this project should have a solid background in cell culture, cellular, molecular biology (transfection, real time PCR, plasmid construction), and biochemistry (Western Blot, co-immunoprecipitation, immunohistochemistry, microscopy, immunoisolation of organelles, protein biochemistry). Experience in electrophysiology would be an advantage.

Candidates:
Interested candidates should e-mail a letter of application, including a CV and the names and addresses of at least two referees to:
  • Aleksander Edelman (aleksander.edelman@inserm.fr), INSERM U1151, Paris, France - tel: +33 (0)6 24 63 34 93
  • Isabelle Sermet-Gaudelus (isabelle.sermet@nck.aphp.fr), INSERM U1151, Paris, France
  • Gergely Lukacs (gergely.lukacs@mcgill.ca), INSERM U1151, Paris, France and McGill University, Montreal Canada

Keywords:
Cystic fibrosis, protein misfolded diseases, exosome, epithelium, lung, CFTR, quality control, inflammation, infection, protein, biochemistry, microRNA, proteomics
Job Posting Form

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 90

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 91
Post-doctoral fellowship at Institut Necker Enfants Malades in Paris
7
An open call for ERC-funded post-doctoral fellowship positions in the lab of Timothy WAI at INEM (Institut Necker Enfants Malades) located in Paris, France (Inserm U1151, CNRS 8253, Paris Descartes University) for the study of metabolic regulation of mitochondrial dynamics.
Mitochondria are dynamic organelles that can undergo dramatic changes in morphology in response to metabolic inputs by adapting the balance between mitochondrial fusion and fission. Mitochondrial fragmentation occurs in response to nutrient excess and cellular dysfunction and has been observed in cardiovascular and neuromuscular disorders, cancer and obesity.
We recently showed that mitochondrial fragmentation drives heart failure, which can be rescued by dietary and metabolic interventions (Wai et al. Science 2015). Our goal is now to understand how metabolic cues from outside the cell are relayed to mitochondria to affect their form and function, with a particular focus on the molecular events at the mitochondrial inner membrane (Wai et al. EMBO reports 2016).
We are looking for highly motivated, enthusiastic and interactive candidates (PhD degree) with experience in cell biology, biochemistry and integrative mouse physiology. Candidates with experience in advanced microscopy and/or mitochondrial biology are particularly encouraged to apply. Good communication skills in English are important and knowledge of French is not required. Appointment is for 2 years with the possibility of renewal. Salary support is commensurate with experience.
More information can be found online about the Wai Lab (wailabinparis.com) and our institute.
Please submit your CV, letter of intent, and the names of two references to with the subject heading: ERC PDF 2017

Deadline for applications is 1 February 2017.

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 90

Notice: Undefined index: in /homepages/40/d483507699/htdocs/inc/global.inc.php on line 91
Post-doc positions available in the Laboratory “Immunity in Health and Disease” at Institut Necker Enfants Malades (INEM), Paris, France
1
The Institut Necker Enfants Malades (INEM) is an interdisciplinary Research Centre of Molecular Medicine with two excellent departments in the fields of “immunology, infectiology, and heamatology” and “cell biology”. The recently established laboratory “Immunity in Health and Disease” is looking for highly motivated post-doctoral scientists interested in studying the regulatory functions of B cells in autoimmune and infectious diseases. The project is funded by a European Research Council (ERC) grant awarded to characterize cytokine-producing regulatory plasma cells and pro-inflammatory B cells in autoimmune and infectious diseases. The project will combine novel state-of-the art in vivo genetic models, as well as cellular and molecular approaches to characterize novel disease-relevant B cell subsets. The candidates should have a strong track record in the field of immunology, cellular immunology, and possibly molecular biology. The laboratory “Immunity in Health and Disease” is at the interface between fundamental and clinical research, and the long-term goal of the project is to derive tools useful in the clinic.
The position is open. Salary will be according to experience.
Please send your application via email in English with CV, a brief outline of previous research, and contact details of three references to:
Simon Fillatreau
INEM
Team 16 – Immunity in Health and Disease
14 Rue Maria Helena Vieira da Silva
75993 Paris Cedex 14
France
Email: ; simonfillatreau@googlemail.com

Selected publications:
  • Shen P. et al. Nature. 2014. vol. 507 p366-370
  • Neves P. et al. Immunity. 2010. vol. 33 p777-790
  • Fillatreau S. et al. Nature Reviews Immunology. 2008. vol. 8 p391-397
  • Fillatreau S. et al. Nature Immunology. 2002. vol. 3 p944-950

  • Notice: Undefined variable: inem_name in /homepages/40/d483507699/htdocs/index.php on line 242

    Notice: Undefined variable: inem_desc in /homepages/40/d483507699/htdocs/index.php on line 243

    Notice: Undefined variable: address in /homepages/40/d483507699/htdocs/location.php on line 17

    Notice: Undefined variable: contact_addr in /homepages/40/d483507699/htdocs/location.php on line 25

    Notice: Undefined index: screen_height in /homepages/40/d483507699/htdocs/index.php on line 335